Corbus Pharmaceuticals (CRBP) Q1 2026 Earnings

9MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.9
-1.67
-1.45
-1.22

Details

Expected EPS
-1.51778
Actual EPS
-1.25
Surprise EPS
0.27
Surprise Percent
+17.64%

Description

Corbus Pharmaceuticals (CRBP) has reported earnings of -1.25 per share for Q1 2026.

0 Comments

Share your thoughts